ADHD Treatment Designed To Fit A Child's Day ™ | Metadate CD (methylphenidate HCl, USP)

Questions about Metadate CD®? Speak to a sales representative: 1-866-540-3376 (TOLL FREE)

INDICATION
Metadate CD^® (methylphenidate HCl, USP) Extended-Release Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

*Metadate CD should not be used in children under 6 years of age since the safety and effectiveness of methylphenidate in children under 6 years of age have not been established.

medication guide | prescribing information | important safety information

References:

Wigal SB, Sanchez DY, DeCory HH, D'Imperio JM, Swanson JM. Selection of the optimal dose ratio for a controlled-delivery formulation of methylphenidate. J Appl Res. 2003;3:46-63.
Gonzalez MA, Pentikis HS, Anderl N, et al. Methylphenidate bioavailability from two extended-release formulations. Int J Clin Pharmacol Ther. 2002;40:175-184.

This site is intended for US residents.

Please see full Prescribing Information by clicking on the links at the top or bottom of this page.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

METADATE CD ^® and Designed To Fit a Child's Day ^® are registered trademarks of the UCB Group of Companies.